A subsequent positron emission tomography (PET) study in living HD sufferers,78 employing 18F-MK9470, a CB1 ligand, demonstrated significant decreases in receptor availability versus controls (p<0.0001). The gene discussed is CNR1; the disease is Huntington disease.